175 Inhibition of β- and γ-secretases as therapeutic targets for Alzheimer's disease
D. Schenk, Sukanto Sinha(Sunesis (United States)), Jeroen Knops(Sunesis (United States)), Peter Seubert(Sunesis (United States)), Lisa McConlogue(Gladstone Institutes), M. Lee(Athena Group (United States)), R. Dovey, Kelly Johnson‐Wood, Ivan Lieberburg(Sunesis (United States)), Dora Games(Athena Group (United States))
Cited by 0
Related Papers
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
|Nature|1995|2.5k
High-Level Neuronal Expression of Aβ<sub>1–42</sub>in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
|Journal of Neuroscience|2000|1.9k
Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
|Nature|1992|1.8k
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
|Proceedings of the National Academy of Sciences|1999|1.1k